Allison C. Hoffman
Net Worth
Last updated:
What is Allison C. Hoffman net worth?
The estimated net worth of Ms. Allison C. Hoffman is at least $6,055,922 as of 15 Oct 2024. She owns shares worth $3,346,961 as insider, has earned $1,640,881 from insider trading and has received compensation worth at least $1,068,080 in Phreesia, Inc..
What is the salary of Allison C. Hoffman?
Ms. Allison C. Hoffman salary is $267,020 per year as Gen. Counsel & Sec. in Phreesia, Inc..
How old is Allison C. Hoffman?
Ms. Allison C. Hoffman is 54 years old, born in 1971.
What stocks does Allison C. Hoffman currently own?
As insider, Ms. Allison C. Hoffman owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Phreesia, Inc. (PHR) | Gen. Counsel & Sec. | 119,791 | $27.94 | $3,346,961 |
What does Phreesia, Inc. do?
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
Allison C. Hoffman insider trading
Phreesia, Inc.
Ms. Allison C. Hoffman has made 24 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently she sold 1,212 units of PHR stock worth $25,482 on 15 Oct 2024.
The largest trade she's ever made was exercising 14,110 units of PHR stock on 26 Aug 2024. As of 15 Oct 2024 she still owns at least 119,791 units of PHR stock.
Phreesia key executives
Phreesia, Inc. executives and other stock owners filed with the SEC:
- Mr. Chaim Indig (46) Co-Founder, Chief Executive Officer & Director
- Mr. David Linetsky (46) Senior Vice President of Life Sciences
- Mr. Evan Roberts (45) Co-Founder & Chief Operating Officer
- Ms. Allison C. Hoffman (54) Gen. Counsel & Sec.